6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
7D2

Konapharma ag

About Konapharma ag

Konapharma is a privately owned Swiss CMO (Contract Manufacturing Organization). A member of Rhenopharma Group together with allpack ag, Kona is focused on the production of solid dosage forms, specialized in MUPS (Multi unit pellet systems), tablets and other retard forms. Kona also holds a special permit to handle and process controlled substances like narcotics and offers a proprietary long acting Methylphenidate formulation. In blistering and packaging Konapharma offers high volume blistering but also “difficult to pack” services for special packaging needs, e.g. inhalation capsules.

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    Switzerland
  • On CPHI since:
    2024
  • Employees:
    100 - 249
Company types
CMO/CDMO
Pharmaceutical company
Contact info